view original post

The trading price of AIkido Pharma Inc. (NASDAQ:AIKI) closed higher on Monday, January 03, closing at $0.62, 5.59% higher than its previous close.

>> 7 Top Picks for the Post-Pandemic Economy <<

Traders who pay close attention to intraday price movement should know that it fluctuated between $0.58 and $0.62. In examining the 52-week price action we see that the stock hit a 52-week high of $2.55 and a 52-week low of $0.57. Over the past month, the stock has lost -11.46% in value.


3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


AIkido Pharma Inc., whose market valuation is $55.01 million at the time of this writing, is expected to release its quarterly earnings report Mar 23, 2022 – Mar 28, 2022. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by $0 per share this quarter, however they have predicted annual earnings per share of $0 for 2013 and $0 for 2014.

Analysts have forecast the company to bring in revenue of $6.5 million for the current quarter, with the likely lows of $6.5 million and highs of $6.5 million. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2013 is $6.5 million.

A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of AIkido Pharma Inc. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest AIKI has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.

A quick review shows that AIKI’s price is currently -5.21% off the SMA20 and -16.64% off the SMA50. The RSI metric on the 14-day chart is currently showing 40.09, and weekly volatility stands at 6.36%. When measured over the past 30 days, the indicator reaches 5.74%. AIkido Pharma Inc. (NASDAQ:AIKI)’s beta value is currently sitting at 1.42, while the Average True Range indicator is currently displaying 0.04.

To see how AIkido Pharma Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: AIKI stock’s performance was 5.59% in the latest trading, and -28.36% in the past year. Also in last trading session, the S&P 500 Index has surged 0.64%, while the Dow Jones Industrial also saw a positive session, up 0.68% on the day.

An evaluation of the daily trading volume of AIkido Pharma Inc. (NASDAQ:AIKI) indicates that the 3-month average is 3.29 million. However, this figure has increased over the past 10 days to an average of 1.78 million.

Currently, records show that 89.63 million of the company’s shares remain outstanding. The insiders hold 0.40% of outstanding shares, whereas institutions hold 16.40%. The stats also highlight that short interest as of Aug 12, 2021, stood at 0.61 million shares, resulting in a short ratio of 0.51 at that time. From this, we can conclude that short interest is 0.68% of the company’s total outstanding shares. It is noteworthy that short shares in August were down slightly from the previous month’s figure, which was 0.72 million. However, since the stock’s price has seen 5.59% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.